TargetMol

Dp44mT

Product Code:
 
TAR-T6821
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T6821-10mg10mg£102.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6821-1mL1 mL * 10 mM (in DMSO)£105.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6821-25mg25mg£122.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6821-50mg50mg£161.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6821-100mg100mg£229.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6821-200mg200mg£278.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Dp44mT, a effective iron chelator, has selective antitumor activity.
CAS:
152095-12-0
Formula:
C14H15N5S
Molecular Weight:
285.37
Pathway:
; Apoptosis; Cell Cycle/Checkpoint
Purity:
0.99
SMILES:
CN(C)C(=S)NN=C(c1ccccn1)c1ccccn1
Target:
Apoptosis; Ferroptosis

References

Rao VA, et al. Cancer Res. 2009, 69(3), 948-957. Jansson PJ, et al. J Biol Chem. 2015, 290(15), 9588-9603. Yuan J, et al. Blood. 2004, 104(5), 1450-1458. Yalowich J C , Wu X , Zhang R , et al. The anticancer thiosemicarbazones Dp44mT and triapine lack inhibitory effects as catalytic inhibitors or poisons of DNA topoisomerase II?[J]. Biochemical Pharmacology, 2012, 84(1):52-58. Whitnall M, et al. A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics. Proc Natl Acad Sci U S A. 2006 Oct 3;103(40):14901-6.